Publications by authors named "Marc De Ryck"

Claim this Profile
C
Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies.
Aliaa Abdelrahman, Vigneshwaran Namasivayam, Sonja Hinz, Anke C Schiedel, Meryem Köse, Marc de Ryck

Biochem Pharmacol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
Henrik Klitgaard, Alain Matagne, Jean-Marie Nicolas, Michel Gillard, Yves Lamberty, Marc De Ryck

Epilepsia· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, anticonvulsant activity, and neuropathic pain-attenuating activity of N-benzyl 2-amino-2-(hetero)aromatic acetamides.
Pranjal K Baruah, Jason Dinsmore, Amber M King, Christophe Salomé, Marc De Ryck

Bioorg Med Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of selective alpha(2C) adrenergic receptor agonists.
Eric Jnoff, Bernard Christophe, Philippe Collart, Francis Coloretti, Aurel Debeuckelaere, Marc De Ryck

ChemMedChem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary amino acid derivatives: substitution of the 4'-N'-benzylamide site in (R)-N'-benzyl 2-amino-3-methylbutanamide, (R)-N'-benzyl 2-amino-3,3-dimethylbutanamide, and (R)-N'-benzyl 2-amino-3-methoxypropionamide provides potent anticonvulsants with pain-attenuating properties.
Amber M King, Christophe Salomé, Elise Salomé-Grosjean, Marc De Ryck, Rafal Kaminski

J Med Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the structural parameters that confer anticonvulsant activity by the site-by-site modification of (R)-N'-benzyl 2-amino-3-methylbutanamide.
Amber M King, Marc De Ryck, Rafal Kaminski, Anne Valade, James P Stables

J Med Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary amino acid derivatives: compounds with anticonvulsant and neuropathic pain protection activities.
Amber M King, Christophe Salomé, Jason Dinsmore, Elise Salomé-Grosjean, Marc De Ryck

J Med Chem· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice.
Yves Lamberty, Eric Detrait, Karine Leclercq, Anne Michel, Marc De Ryck

Behav Brain Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UCB Pharma research day-25 October 2007 'Glia-neuron interactions and purinergic receptors in neurological disorders'.
Geoffrey Burnstock, Marc De Ryck

Purinergic Signal· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin therapy for acute stroke is both safe and beneficial.
Hannelore Ehrenreich, Martin Hasselblatt, Christoph Dembowski, Lukas Cepek, Piotr Lewczuk, Marc De Ryck

Mol Med· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis